As of 2025-07-04, the Relative Valuation of Cue Biopharma Inc (CUE) is (11.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1775.4%.
The range of the Relative Valuation is (9.43) - (13.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 24.2x | 20.0x |
| Forward P/E multiples | 17.5x - 28.9x | 23.2x |
| Fair Price | (9.43) - (13.05) | (11.65) |
| Upside | -1455.8% - -1976.4% | -1775.4% |
| Date | P/E |
| 2025-07-01 | -1.25 |
| 2025-06-30 | -1.27 |
| 2025-06-27 | -1.38 |
| 2025-06-26 | -1.47 |
| 2025-06-25 | -1.46 |
| 2025-06-24 | -1.34 |
| 2025-06-23 | -1.22 |
| 2025-06-20 | -1.30 |
| 2025-06-18 | -1.22 |
| 2025-06-17 | -1.08 |
| 2025-06-16 | -1.10 |
| 2025-06-13 | -1.12 |
| 2025-06-12 | -1.18 |
| 2025-06-11 | -1.19 |
| 2025-06-10 | -1.18 |
| 2025-06-09 | -1.18 |
| 2025-06-06 | -1.19 |
| 2025-06-05 | -1.17 |
| 2025-06-04 | -1.15 |
| 2025-06-03 | -1.17 |
| 2025-06-02 | -1.21 |
| 2025-05-30 | -1.18 |
| 2025-05-29 | -1.20 |
| 2025-05-28 | -1.17 |
| 2025-05-27 | -1.23 |
| 2025-05-23 | -1.23 |
| 2025-05-22 | -1.31 |
| 2025-05-21 | -1.12 |
| 2025-05-20 | -1.24 |
| 2025-05-19 | -1.31 |
| 2025-05-16 | -1.35 |
| 2025-05-15 | -1.34 |
| 2025-05-14 | -1.38 |
| 2025-05-13 | -1.43 |
| 2025-05-12 | -1.39 |
| 2025-05-09 | -1.45 |
| 2025-05-08 | -1.43 |
| 2025-05-07 | -1.43 |
| 2025-05-06 | -1.39 |
| 2025-05-05 | -1.44 |
| 2025-05-02 | -1.40 |
| 2025-05-01 | -1.40 |
| 2025-04-30 | -1.40 |
| 2025-04-29 | -1.42 |
| 2025-04-28 | -1.47 |
| 2025-04-25 | -1.46 |
| 2025-04-24 | -1.59 |
| 2025-04-23 | -1.55 |
| 2025-04-22 | -1.45 |
| 2025-04-21 | -1.45 |